Trigger, pathogen, or bystander: the complex nexus linking Epstein Barr virus and multiple sclerosis
|
|
- Audra Mills
- 5 years ago
- Views:
Transcription
1 8109MSJ / Owens and BennettMultiple Sclerosis Journal Topical Review MULTIPLE SCLEROSIS JOURNAL MSJ Trigger, pathogen, or bystander: the complex nexus linking Epstein Barr virus and multiple sclerosis Multiple Sclerosis Journal 18(9) The Author(s) 2012 Reprints and permissions: sagepub.co.uk/journalspermissions.nav DOI: / msj.sagepub.com Gregory P Owens 1 and Jeffrey L Bennett 2 Abstract A causal role for virus infection in the pathophysiology of multiple sclerosis (MS) has been suggested and widely debated since the landmark epidemiologic studies of Kurtzke revealed a strong environmental determinant to MS susceptibility. Despite multiple efforts, no virus has been unequivocally associated with lesion formation in the brain either by direct isolation or by indirect methods of detection. In many infectious diseases of the central nervous system, oligoclonal IgG bands are the product of a robust and specific humoral response against the causative agent; yet in MS, immunoreactivity to a primary target has been elusive. In the absence of any infectious agent fulfilling Koch s Postulates, new concepts that could plausibly explain the epidemiology of MS have been postulated. The initiation or activation of a nascent autoimmune response in genetically susceptible individuals following exposure to one or more common infectious agents is now a leading hypothesis to explain MS pathogenesis. Epstein Barr Virus (EBV), a human herpes virus that infects B cells in ~95% of the human population and persists latently in the memory B cell pool throughout life, has received the most attention as a probable candidate; EBV has been implicated as both an environmental trigger and as a direct causative agent of CNS immunopathology. In this review, we will discuss the most salient features of EBV epidemiology, the immunological response to EBV in MS patients and whether EBV infection of the brain is a necessary prerequisite of MS pathology. Keywords demyelination, multiple sclerosis Date received: 13th April 2012; accepted: 19th April 2012 A causal role for virus infection in the pathophysiology of multiple sclerosis (MS) has been suggested and widely debated since the landmark epidemiologic studies of Kurtzke revealed a strong environmental determinant to MS susceptibility. 1 Despite multiple efforts, no virus has been unequivocally associated with lesion formation in the brain either by direct isolation or by indirect methods of detection. Likewise, attempts to link the intrathecal production of immunoglobulin (Ig) and IgG oligoclonal bands to a specific infection have generated a confounding and contradictory body of literature. In many infectious diseases of the CNS, oligoclonal IgG bands are the product of a robust and specific humoral response against the causative agent; yet in MS, immunoreactivity to a primary target has been elusive. In the absence of any infectious agent fulfilling Koch s Postulates, new concepts that could plausibly explain the epidemiology of MS have been postulated. The initiation or activation of a nascent autoimmune response in genetically susceptible individuals following exposure to one or more common infectious agents is now a leading hypothesis to explain MS pathogenesis. 2 Epstein Barr virus (EBV), a human herpes virus that infects B cells in ~95% of the human population and persists latently in the memory B cell pool throughout life, has received the most attention as a probable candidate; 3 EBV has been implicated as both an environmental trigger and as a direct causative agent of central nervous system (CNS) immunopathology. In this review, we will discuss the most salient features of EBV epidemiology, the immunological response to EBV in MS patients and whether EBV 1 Department of Neurology, University of Colorado Denver, USA. 2 Departments of Neurology and Ophthalmology University of Colorado Denver, USA. Corresponding author: Gregory P Owens, University of Colorado Denver, Department of Neurology, E. 19th Avenue, Research Complex 2, Box B-182 Room 5004, Aurora, CO 80045, USA. greg.owens@ucdenver.edu
2 Owens and Bennett 1205 infection of the brain is a necessary prerequisite of MS pathology. Infection with EBV and risk of MS There is a persuasive body of evidence linking EBV infection to MS risk. The 5% of the human population without detectable EBV infection have a remarkably low risk for developing MS. In a review of case-control studies, Ascherio and Munch found the incidence of MS to be significantly higher (odds ratio = 13.5) in EBV seropositive compared with seronegative individuals. 4 A more recent study that analyzed serial serum samples from US military personnel for EBV antibodies (Abs) identified 10 healthy patients who were EBV-negative at their time of enrollment, but subsequently developed clinical MS. All 10 of the MS patients became infected with EBV prior to their diagnosis. In comparison, a significantly lower rate (35.7%) of EBV infection over the same time interval was observed in a cohort of age- and sex-matched controls. 5 An associated risk for MS following EBVinfection, but not cytomegalovirus- or HSV1-infection, was also found in cases of pediatric MS, 6,7 and individuals who acquire EBV during adolescence or later, as manifested by infectious mononucleosis, are at an additional 2 3-fold higher risk to develop MS than children infected early in life. 8,9 Heightened humoral immune responses to EBV are found in individuals with MS. Notable differences in antibody titers to EBV antigens, particularly EBNA-1 and the nuclear EBNA complex, are detected in MS patients up to five years before the diagnosis of disease. Compared with matched controls, increased EBV Ab titers indicate an increased risk for developing MS disease and are suggested to be an early event in the disease process. 10,11 The association between enhanced EBV immunity and the role of EBV as a causative agent is complicated by elevated Ab titers in MS serum and cerebrospinal fluid (CSF) to many common viruses and infections prevalent within the human population, which may be more indicative of an overall immune dysregulation of B cell memory responses. 12 Unlike EBV, however, epidemiologic evidence does not show an increased risk of MS following exposure to many other common viral infections including measles, rubella, mumps, HSV-1 and VZV. 13 Cellular immunity is also somewhat altered in MS patients relative to healthy controls. Generally, there are increased numbers of circulating EBV-specific CD8+ cells but not EBV-specific CD4+ T cells, the exception being EBNA EBNA-1-specific memory CD4+ T cells are elevated in MS blood, show increased proliferative capacity and possess higher avidity and broadened peptide specificity compared with demographically and HLA-DRmatched controls. Although the epidemiologic and immunologic data provide a compelling connection between exposure to EBV and risk of MS, alternative explanations that do not necessitate a direct causal link cannot be excluded, the most likely being a shared susceptibility for MS and EBV infection. Indeed, recent work has shown that the mechanism through which class I and class II HLA genes influence the risk of MS may similarly affect the immune control of EBV infection. 15 EBV infection of the brain Disease mechanisms linking EBV infection to MS pathology are to date largely hypothetical. Autoreactive T cells could be activated by EBV through molecular mimicry, as demonstrated in vitro for MBP-specific T cell clones derived from blood of MS patients. 16 Alternatively, enhanced breakdown and presentation of self-antigens, expression of viral superantigens or bystander activation could be putative mechanisms by which EBV infection promotes CNS inflammation. 17 Perhaps most contentious is a direct role for EBV infection in CNS inflammation as a consequence of potential selective enrichment of EBV-infected B cells in ectopic meningeal follicles and perivascular CNS inflammatory infiltrates in MS brain. In 2007, Serafini and colleagues 18 reported that ~90% of B-lymphocytes in meningeal B cell follicles and in perivascular cuffs of multiple acute and chronic active white matter lesions expressed EBV nuclear transcripts (EBERs) that were identified by in situ hybridization; 50 80% of parenchymal plasma cells were also EBERs positive. EBV proteins, LMP1 and LMP2a, were detected by immunohistochemistry and in very severe MS cases of short disease-duration, evidence for the EBV lytic cycle was suggested by numerous cells immunostained with antibody to the early-lytic cycle-associated protein BFRF1. The robust presence of EBV-infected B cells in close to 100% of MS cases examined in this study stands in stark contrast to several later publications that rarely detected EBV in MS brain specimens Concurring reports by Willis et al. 19 and Peferoen et al. 20 found little evidence for EBV infection in a large sampling of MS brain tissue using similar in situ hybridization methodologies. The Willis study examined 23 blocks from 12 MS specimens that were clearly demonstrated to contain CD20+ B cell infiltrates. Peferoen et al. examined 632 brain sections from 94 MS patients for EBV infection, including 12 of the same tissue blocks previously identified as EBV-positive. 20 Although B cells in EBVassociated control tumors were positive by hybridization to EBV-encoded RNA, only one MS sample in these two studies was EBERs positive. In the absence of detectable EBV RNA by in situ hybridization, Willis et al. developed sensitive real-time PCR assays that could amplify EBV genomic DNA or EBER1 RNA from one or two EBV-infected cells processed in the presence of human brain tissue. 19 Using their real-time PCR assay, Willis et al. identified EBV in 0/17 MS white matter sections and in 2/12 MS meningeal sections including
3 1206 Multiple Sclerosis Journal 18(9) identical tissue samples evaluated in the Serafini study. 18 Our research group was also intrigued by the possibility of a chronic active EBV infection in MS brain and attempted to detect EBV transcripts from single FACS-sorted MS CSF B and plasma blast cell populations and from MS brain tissue. 21 Because plasma blasts in MS CSF are clonally expanded and are cells contributing to the production of CSF IgG oligoclonal bands, 22 we reasoned that a prominent infection of CNS B cells would be detectable within this population, a view validated by repertoire studies showing a strong clonal continuum between B cells populating the meninges, brain parenchyma and CSF of MS patients. 23 Using real-time PCR with a pre-amplification step to detect EBER1 and a cellular gene (RPLP0) in single cells, we failed to identify EBER1 transcripts in 274 single plasma blast cells and 57 single CD19+ B cells sorted from four different MS CSF donors. EBER1 was detected in 100% of single EBV-infected B cells processed in the same manner and RPLP0 was detected in all of the single B and plasma cells analyzed. Fifteen plaques from US and UK tissue banks were further studied for EBV and control gene transcripts. Four of the lesions were verified to contain perivascular B cell infiltrates and another five were previously shown to carry a high EBV-load in the Serafini study 18. Although we readily detected cellular transcripts for GAPDH, human IgG and RPLP0, EBV-specific transcripts (EBER1, EBNA-2, LMP-1 and BFRF-1) were not detected in any of the MS lesions, but were amplified from control EBV-infected lymphomas. The only MS tissues in which EBV transcripts were detected using real-time PCR had been prescreened for EBV DNA from a larger sample of MS brain sections. When a series of paraffin-embedded MS tissue sections including three EBV DNA-positive sections were assayed blinded, we only detected EBER1 RNA, but not other EBV transcripts, indicating the presence of rare Stage 0 latently EBV-infected B cell in these samples. Together, the above three studies concluded that EBVinfection in MS brain tissue is a rare event and unlikely to be a direct cause of CNS inflammation. Two other studies attempting to amplify EBV DNA from MS brain tissue also found EBV infection to be an infrequent event. 24,25 More recently, Aloisi et al. countered that EBV latency transcripts (LMP2a and EBNA-1) are present in MS tissue by PCR, but require pre-amplification from B cell infiltrates that were obtained from MS brain samples by laser-microdissection. 26 They suggested that the previous PCR assays may have been insensitive and limited EBV detection. They also indicated that EBV-infection of the brain is more limited than previously reported. To address the largely divergent body of literature regarding the presence of EBV and its relationship to MS brain inflammation, a workshop was held in Vienna in 2010 under the umbrella of the European Union NeuroProMiSe project. Although a consensus was not reached, a majority view held that EBV-infection of B cells in the brain, if present at all, is limited to very few cells. Issues regarding the specificity and sensitivity of individual assays used to detect EBV were discussed in detail and have been presented in a summary publication. 27 Without recapitulating the many arguments presented in this review, several additional points bear further emphasis. (1) EBERs transcripts are normally quite abundant (>1,000,000 copies per cell) in EBV-infected B cells. The observation that other B cellspecific transcripts including CD20 and IgG were routinely detected by PCR in the MS tissues studied indicates that EBER1 and other EBV transcripts, if present in a high percentage of B cells, should have been detected unless EBERs expression is somehow down-regulated in the CNS. (2) The sensitivity argument does not explain the absence of EBV transcripts in individually FACS-sorted MS CSF plasma blasts and B cells. The idea that CSF B cells are somehow distinct from those in the meninges and brain parenchyma is not supported experimentally. As described above, detailed sequence analyses show that B cell populations within the different compartments of the CNS share a common lineage and bear the phenotype of antigen-selection. 23 (3) Tissue selection has also been suggested as an explanation for the discrepancy in results, even though many of the sections examined in this series of studies are from the same MS patients, tissue banks and, in the Perforoen study, included sections from the exact same tissue block. A recent paper, which was also discussed at the Vienna meeting, reported abundant EBV-positive B cells, including some lytically-infected B cells, in active MS lesions that were characterized by the presence of MHC class II+ cells expressing interferon α (IFN-α). 28 The specificity of the in situ hybridization protocol and/or specificity of EBVinfection to MS brain was somewhat compromised by the presence of EBV-positive cells (presumably B cells) in two stroke brains but not in normal control brain. Subacute sclerosing panencephalitis (SSPE) brain tissue, which is usually highly-infiltrated with B cells, was EBERs negative as well. However, because SSPE is a rare consequence of measles virus infection that occurs primarily in the young, the unknown EBV status of the patient is an important consideration in interpreting results. Whether EBV-infected cells are driving IFN-α production through stimulation of innate TLR3 receptors via the release of EBERs RNA, as suggested by some additional preliminary evidence in this article, or are coincidental to CNS inflammation and demyelination will likely be addressed in future studies. Lastly (4), the notion of EBV driving CNS inflammation is not uniformly supported by studies of the intrathecal immune response. Although enhanced EBV immunity is a feature of MS serology, it does not necessarily translate to antibody responses in CSF. Although one study did show enhanced CSF immunoreactivity to the EBV-specific proteins BRRF2 and EBNA-1 in MS patients, 29 our analyses of paired CSF and serum samples found little evidence for a disease-specific intrathecal Ab response to EBV antigens. 21
4 Owens and Bennett 1207 Figure 1. Possible interactions linking Epstein Barr virus (EBV) infection to risk of multiple sclerosis. CNS: central nervous system A determination of the CSF IgG index to EBV antigens revealed indices >0.7 in 85% (17/20) of MS CSFs and 60% of non-ms CNS inflammatory disease controls. Patients with an IgG index (>1.5) indicative of intrathecal synthesis of anti-ebv IgG antibody did not differ significantly between MS (3/20) and non-ms CNS inflammatory disease controls (2/5). We further tested recombinant Abs generated from clonally expanded MS CSF plasma cells for binding to EBV antigens. While EBV-infected B95-8 cells were readily stained with control anti-ebv-gp125 antibody and with MS and control CSF, none of the 32 recombinant Abs derived from four patients with relapsing or progressive MS bound to EBV-infected cells. Other studies of Ab responses in MS CSF, including samples obtained at the time of their first clinical event and from pediatric cases, also found intrathecal anti-ebv antibody synthesis to be rare or comparable in frequency to the poly-specific response observed for other common infectious agents Future directions After years of investigation, the exact relationship between EBV infection and MS remains unclear and may involve totally unexplored areas of cause and effect (Figure 1). Epidemiologic data indicate a significant association between EBV infection and MS risk; however, confusing correlation with causation is a long-standing pitfall in research. Is the link between EBV and MS immunologic? Are there MS risk alleles that incur susceptibility to EBV infection or significantly alter the immune response to EBV? Or, does the pathophysiology of MS foster susceptibility to EBV infection? If so, then genetic and immunologic studies comparing the genotypes and immune responses of EBV-infected individuals with and without MS may be directly informative. Alternatively, is the link between EBV and MS causal? Does MS result from a persistent or dysregulated EBV infection? Or does an altered immune response to EBV infection trigger or perpetuate demyelinating disease? 33 Although implicated in the etiology of multiple immunologic disorders such as MS, systemic lupus erythematosus and rheumatoid arthritis, evidence that EBV causes autoimmunity falls short of the strong evidence supporting the role of the virus in lymphoid malignancy. Future research supporting a causal link between EBV and MS will need to show either a reproducible presence of EBV-infected lymphocytes in affected CNS tissue or demonstrate a mechanistic link between a dysregulated EBV immune response and MS immunopathology. Funding This research was supported by Grant Number R01NS from the National Institute Of Neurological Disorders And Stroke to G.P.O, and by funding from the National Multiple Sclerosis Society (Grant Number RG4320) and Guthy-Jackson Foundation to J.L.B. The content is solely the responsibility of the authors and does not necessarily represent official views of the funding agencies. Conflict of interest statement The authors declare that there is no conflict of interest. References 1. Kurtzke JF. Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev 1993; 6:
5 1208 Multiple Sclerosis Journal 18(9) 2. Hunter SF and Hafler DA. Ubiquitous pathogens; links between infection and autoimmunity in MS? Neurology 2000; 55: Cohen JI. Epstein BarrVirus Infection. N Engl J Med 2000; 343: Ascherio A and Munch M. Epstein Barr virus and multiple sclerosis. Epidemiology 2000; 11: Levin LI, Munger KL, O Reilly EJ, et al. Primary infection with the Epstein-Barr virus and the risk of multiple sclerosis. Ann Neurol 2010; 67: Alotaibi S, Kennedy J, Tellier R, et al. Epstein-Barr virus in pediatric multiple sclerosis JAMA 2004; 291: Pohl D, Krone B, Rostasy K, et al. High seroprevalence of Epstein Barr virus in children with multiple sclerosis. Neurology 2006; 67: Thacker EL, Mirzaei F and Aschero A. Infectious mononucleosis and risk for multiple sclerosis: A meta-analysis. Ann Neurol 2006; 59: Nielsen TR, Rostgaard K, Nielsen NM, et al. Multiple sclerosis after infectious mononucleosis. Arch Neurol 2007; 64: Ascherio A, Munger K, Lennette E, et al. Epstein Barr virus antibodies and risk of multiple sclerosis: A prospective study. JAMA 2001; 286: Levin LI, Munger KL, Rubertone MV, et al. Temporal relationship between elevation of Epstein Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 2005; 293: Sindic CJ, Monteyne P and Laterre EC. The intrathecal synthesis of virus-specific oligoclonal IgG in multiple sclerosis. J Neuroimmunol 1994; 54: Ascherio A and Munger K. Environmental risk factors for multiple sclerosis. Part I: The role of infection. Ann Neurol 2007; 61: Lünemann JD, Edwards N, Murano PA, et al. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Brain 2006; 129: Sundqvist E, Sundström P, Hedström AK, et al. Epstein Barr virus and multiple sclerosis; interaction with HLS. Genes Immun 2012; 13: Wucherpfennig KW and Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995; 80: Wucherpfennig KW. Mechanisms for the induction of autoimmunity by infectious agents. J Clin Invest 201; 108: Serafini B, Rosicarelli B, Franciotta D, et al. Dysregulated Epstein Barr virus infection in the multiple sclerosis brain. J Exp Med 2007; 204: Willis S, Stadelmann C, Rodig S, et al. Epstein Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain 2009; 132: Peferoen LAN, Lamers F, Lodder LNR, et al. Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis. Brain 2010; 133: Sargsyan SA, Shearer AJ, Ritchie AM, et al. Absence of Epstein Barr virus in the brain and CSF of patients with multiple sclerosis. Neurology 2010; 74: Obermeier B, Mentele R, Malotka J, et al. Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis. Nat Med 2008; 14: Lavato L, Willis SN, Rodig SJ, et al. Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis. Brain 2011; 134: Sanders V, Felisan S, Waddell A, et al. Detection of herpesviridae in postmortem multiple sclerosis brain and controls by polymerase chain reaction. J Neurovirol 1996; 2: Torskilden O, Stansberg C, Anglelskar SM, et al. Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients. Brain Path 2010; 20: Aloisi F, Serafini B, Magliozzi R, et al. Detection of Epstein Barr virus and B-cell follicles in the multiple sclerosis brain: What you find depends on how and where you look. Brain 2010; 133: Lassmann H, Niedobitek G, Aloisi F, et al.; the NeuroproMiSe EBV Working Group. Epstein Barr virus in the multiple sclerosis brain: A controversial issue-report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria. Brain 201; 134: Tzartos JS, Khan G, Vossenkamper A, et al. Association of innate immune activation with latent Epstein Barr virus in active MS lesions. Neurology 2012; 78: Cepok S, Zhou D, Srivastava R, et al. Identification of Epstein Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest 2005; 115: Jafari N, van Nierop GP, Verjans G, et al. No evidence for intrathecal IgG synthesis to Epstein Barr virus nuclear antigen-1 in multiple sclerosis. J Clin Virol 2010; 49: Pohl D, Rostasy K, Jacobi C, et al. Intrathecal antibody production against Epstein Barr and other neurotropic viruses in pediatric and adult onset multiple sclerosis. J Neurol 2010; 257: Otto C, Oltmann A, Stein A, et al. Intrathecal EBV antibodies are part of the polyspecific immune response in multiple sclerosis. Neurology 2011; 76: Niller N, Wolf H and Minarovits J. Regulation and dysregulation of Epstein Barr virus latency: Implications for the development of autoimmune diseases. Autoimmunity 2008; 41:
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain
ARTICLE Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain Barbara Serafini, 1 Barbara Rosicarelli, 1 Diego Franciotta, 2 Roberta Magliozzi, 3 Richard Reynolds, 3 Paola Cinque, 4
More informationInfection of Autoreactive B Lymphocytes with EBV, Causing Chronic Autoimmune Diseases
Infection of Autoreactive B Lymphocytes with EBV, Causing Chronic Autoimmune Diseases Michael P. Pender (Department of Medicine, The University of Queensland, Clinical Sciences Building, Royal Brisbane
More informationInfection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases
584 Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases Michael P. Pender Department of Medicine, The University of Queensland, Clinical Sciences Building, Royal Brisbane
More informationSUSPECTED MECHANISMS INVOLVED IN MS AND PUTATIVE INTERACTIONS WITH HEPATITIS B VACCINE IN MS
SUSPECTED MECHANISMS INVOLVED IN MS AND PUTATIVE INTERACTIONS WITH HEPATITIS B VACCINE IN MS Emmanuelle Waubant, M.D. Olaf Stüve, M.D., PhD UCSF MS Center, San Francisco March 11, 2002 EPIDEMIOLOGY OF
More informationMechanisms of Autontibodies
Mechanisms of Autontibodies Production in Rheumatic Diseases Eisa Salehi PhD Tehran University of Medical Sciences Immunology Department Introduction Rheumatic diseases: Cause inflammation, swelling, and
More informationHigh anti-ebna-1 IgG levels are associated with early-onset myasthenia gravis
European Journal of Neurology 2012, 19: 842 846 doi:10.1111/j.1468-1331.2011.03636.x High anti-ebna-1 IgG levels are associated with early-onset myasthenia gravis D. Csuka a, M. Banati b, C. Rozsa c,g.füst
More informationDetection of Epstein-Barr virus in the multiple sclerosis brain
Detection of Epstein-arr virus in the multiple sclerosis brain Francesca Aloisi Department of Cell iology and Neuroscience Istituto Superiore di Sanità Rome, Italy rainnet Europe II Munich, 12 December
More informationالحترمونا من خري الدعاء
الحترمونا من خري الدعاء Instructions for candidates The examination consists of 30 multiple choice questions, each divided into 5 different parts. Each part contains a statement which could be true or
More informationTemporal Relationship Between Elevation of Epstein-Barr Virus Antibody Titers and Initial Onset of Neurological Symptoms in Multiple Sclerosis
ORIGINAL CONTRIBUTION Temporal Relationship Between Elevation of Epstein-Barr Virus Antibody Titers and Initial Onset of Neurological Symptoms in Multiple Sclerosis Lynn I. Levin, PhD, MPH Kassandra L.
More informationAutoimmunity Reviews
Autoimmunity Reviews 11 (2011) 88 97 Contents lists available at SciVerse ScienceDirect Autoimmunity Reviews journal homepage: www.elsevier.com/locate/autrev Review Autoimmune disease: A role for new anti-viral
More informationAND RELAPSING REMITTING COURSES
original research THE VALUE OF INTRATHECAL MRZ REACTION AND OLIGOCLONAL IgG BANDS FOR DISCRIMINATION BETWEEN THE PRIMARY PROGRESSIVE AND RELAPSING REMITTING COURSES OF MULTIPLE SCLEROSIS Štourač P. 1,
More informationAn altered immune response to Epstein- Barr virus in multiple sclerosis
An altered immune response to Epstein- Barr virus in multiple sclerosis A prospective study P. Sundström, MD, PhD; P. Juto, MD, PhD; G. Wadell, MD, PhD; G. Hallmans, MD, PhD; A. Svenningsson, MD, PhD;
More informationPersistent Infections
Persistent Infections Lecture 17 Biology 3310/4310 Virology Spring 2017 Paralyze resistance with persistence WOODY HAYES Acute vs persistent infections Acute infection - rapid and self-limiting Persistent
More informationClinical Aspect and Application of Laboratory Test in Herpes Virus Infection. Masoud Mardani M.D,FIDSA
Clinical Aspect and Application of Laboratory Test in Herpes Virus Infection Masoud Mardani M.D,FIDSA Shahidhid Bh BeheshtiMdi Medical lui Universityit Cytomegalovirus (CMV), Epstein Barr Virus(EBV), Herpes
More informationRelation between Epstein-Barr virus and multiple sclerosis: analytic study of scientific production
Relation between Epstein-Barr virus and multiple sclerosis: analytic study of scientific production O. Santiago, J. Gutierrez, A. Sorlozano, J. Dios Luna, E. Villegas, O. Fernandez To cite this version:
More informationNeuroimmunology. Innervation of lymphoid organs. Neurotransmitters. Neuroendocrine hormones. Cytokines. Autoimmunity
Neuroimmunology Innervation of lymphoid organs Neurotransmitters Neuroendocrine hormones Cytokines Autoimmunity CNS has two ways of contacting and regulating structures in the periphery Autonomic
More informationCerebrospinal Fluid EBV Replication is Associated with Compartmental Inflammation and Pleocytosis in HIV-positive naïve and Treated Individuals
Cerebrospinal Fluid EBV Replication is Associated with Compartmental Inflammation and Pleocytosis in HIV-positive naïve and Treated Individuals Lupia T, Milia MG, Atzori C, Audagnotto S, Imperiale D, Romito
More informationDetermination of the temporal pattern and importance of BALF1 expression in Epstein-Barr viral infection
Determination of the temporal pattern and importance of BALF1 expression in Epstein-Barr viral infection Melissa Mihelidakis May 6, 2004 7.340 Research Proposal Introduction Apoptosis, or programmed cell
More informationWhat is Autoimmunity?
Autoimmunity What is Autoimmunity? Robert Beatty MCB150 Autoimmunity is an immune response to self antigens that results in disease. The immune response to self is a result of a breakdown in immune tolerance.
More informationWhat is Autoimmunity?
Autoimmunity What is Autoimmunity? Robert Beatty MCB150 Autoimmunity is an immune response to self antigens that results in disease. The immune response to self is a result of a breakdown in immune tolerance.
More informationImmunity to Viruses. Patricia Fitzgerald-Bocarsly September 25, 2008
Immunity to Viruses Patricia Fitzgerald-Bocarsly September 25, 2008 The Immune System Deals with a Huge Range of Pathogens Roitt, 2003 Immune Responses to Viruses Viruses are dependent on the host cell
More informationHerpesviruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics
Herpesviruses Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Virion Enveloped icosahedral capsid (T=16), diameter 125 nm Diameter of enveloped virion 200 nm Capsid
More informationEBV Infection and Immunity. Andrew Hislop Institute for Cancer Studies University of Birmingham
EBV Infection and Immunity Andrew Hislop Institute for Cancer Studies University of Birmingham EBV Introduction Large ds DNA virus Spread by saliva contact Lifelong infection Predominantly B-lymphotropic
More informationThe pathogenesis of nervous distemper
Veterinary Sciences Tomorrow - 2004 The pathogenesis of nervous distemper Marc Vandevelde Canine distemper is a highly contagious viral disease of dogs and of all animals in the Canidae, Mustellidae and
More informationContents 1 Immunology for the Non-immunologist 2 Neurology for the Non-neurologist 3 Neuroimmunology for the Non-neuroimmunologist
1 Immunology for the Non-immunologist... 1 1 The Beginnings of Immunology... 1 2 The Components of the Healthy Immune Response... 2 2.1 White Blood Cells... 4 2.2 Molecules... 8 References... 13 2 Neurology
More informationTheiler s Murine Encephalomyelitis Virus-Induced CNS Autoimmunity
Theiler s Murine Encephalomyelitis Virus-Induced CNS Autoimmunity Virus-induced molecular mimicry is part of a mouse model of multiple sclerosis that is providing insights about the disease in humans Julie
More informationVaccinations against Hepatitis B Virus: a summary of the discussions of the National Advisory Board of Pharmacovigilance of September 30th, 2008
FRENCH REPUBLIC Press release October 1st, 2008 Vaccinations against Hepatitis B Virus: a summary of the discussions of the National Advisory Board of Pharmacovigilance of September 30th, 2008 The National
More informationElevated EBNA-1 IgG in MS is associated with genetic MS risk variants
Elevated EBNA-1 IgG in MS is associated with genetic MS risk variants Karim L. Kreft, MD, PhD* Gijsbert P. Van Nierop, BASc* Sandra M.J. Scherbeijn, BASc Malou Janssen, MSc Georges M.G.M. Verjans, PhD
More informationEpstein-Barr Virus (EBV) Infection in Epithelial Cells In Vivo: Rare Detection of EBV Replication in Tongue Mucosa but Not in Salivary Glands
BRIEF REPORT Epstein-Barr Virus (EBV) Infection in Epithelial Cells In Vivo: Rare Detection of EBV Replication in Tongue Mucosa but Not in Salivary Glands Phroso Frangou, Maike Buettner, and Gerald Niedobitek
More informationLab 3: Pathogenesis of Virus Infections & Pattern 450 MIC PRACTICAL PART SECTION (30397) MIC AMAL ALGHAMDI 1
Lab 3: Pathogenesis of Virus Infections & Pattern 450 MIC PRACTICAL PART SECTION (30397) 2018 450 MIC AMAL ALGHAMDI 1 Learning Outcomes The pathogenesis of viral infection The viral disease pattern Specific
More informationEBV infection B cells and lymphomagenesis. Sridhar Chaganti
EBV infection B cells and lymphomagenesis Sridhar Chaganti How EBV infects B-cells How viral genes influence the infected B cell Differences and similarities between in vitro and in vivo infection How
More informationCOPYRIGHT 2012 THE TRANSVERSE MYELITIS ASSOCIATION. ALL RIGHTS RESERVED
The Transverse Myelitis Association...advocating for those with acute disseminated encephalomyelitis, neuromyelitis optica, optic neuritis and transverse myelitis ACUTE DISSEMINATED ENCEPHALOMYELITIS (ADEM)
More informationThe anti-inflammatory enzyme A20 in the neuropathology of Multiple Sclerosis
More Than Neurons, 1-3 December, Turin The anti-inflammatory enzyme A20 in the neuropathology of Multiple Sclerosis Dr. Simona Perga, PhD Neuroscience Institute Cavalieri Ottolenghi (NICO) & Multiple Sclerosis
More informationANTIBODIES TO HERPES-SIMPLEX VIRUS IN THE CEREBROSPINAL FLUID OF PATIENTS WITH HER- PETIC ENCEPHALITIS
ANTIBODIES TO HERPES-SIMPLEX VIRUS IN THE CEREBROSPINAL FLUID OF PATIENTS WITH HER- PETIC ENCEPHALITIS F. 0. MACCALLUM, I. J. CHINN AND J. V. T. GOSTLMG Virology Laboratory, Radclife Infirmary, Oxford
More informationMucosal Immune System
Exam Format 100 points - 60 pts mandatory; 40 points where 4, 10 point questions will be chosen Some open-ended questions, some short answer. Kuby question Cytokines Terminology How do cytokines achieve
More informationReport of the Wolfson Institute Workshop on Epstein Barr Virus Infection and Multiple Sclerosis Prevention
Embargo: not for publication or quotation before 00.01 hours Tuesday June 27th 2017 Wolfson Institute of Preventive Medicine Report of the Wolfson Institute Workshop on Epstein Barr Virus Infection and
More informationdoi: /brain/awq350 Brain 2011: 134; Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis
doi:10.1093/brain/awq350 Brain 2011: 134; 534 541 534 BRAIN A JOURNAL OF NEUROLOGY Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis Laura Lovato, 1,2 Simon
More informationPrinciples of Adaptive Immunity
Principles of Adaptive Immunity Chapter 3 Parham Hans de Haard 17 th of May 2010 Agenda Recognition molecules of adaptive immune system Features adaptive immune system Immunoglobulins and T-cell receptors
More informationMultiple sclerosis (MS) is generally considered to be a complex disorder. Does Epstein-Barr Virus Cause Multiple Sclerosis?
ETIOLOGY UPDATE Does Epstein-Barr Virus Cause Multiple Sclerosis? Stuart D. Cook, MD Department of Neurology and Neurosciences, New Jersey Medical School, University of Medicine and Dentistry of New Jersey,
More informationEBV Infection. > Cellular Immune Response Profiling. > Humoral Immune Response Profiling EBV. ImmunoTools
EBV ImmunoTools Peptide Tools to Study EBV EBV Infection > Cellular Immune Response Profiling Antigen spanning EBV PepMix Peptide Pools PepMix Collection EBV > Humoral Immune Response Profiling EBV RepliTope
More informationAll animals have innate immunity, a defense active immediately upon infection Vertebrates also have adaptive immunity
1 2 3 4 5 6 7 8 9 The Immune System All animals have innate immunity, a defense active immediately upon infection Vertebrates also have adaptive immunity Figure 43.2 In innate immunity, recognition and
More informationImmunology of Multiple Sclerosis
Immunology of Multiple Sclerosis Michael P. Pender, MD, PhD, FRACP, and Judith M. Greer, PhD Corresponding author Michael P. Pender, MD, PhD, FRACP Neuroimmunology Research Centre, Clinical Sciences Building,
More informationOverview of role of immunologic markers in HIV diagnosis
Overview of role of immunologic markers in HIV diagnosis Savita Pahwa, M.D. Departments of Microbiology & Immunology and Pediatrics University of Miami, Miller School of Medicine, Miami, Florida Background:
More informationAutoimmune Diseases. Betsy Kirchner CNP The Cleveland Clinic
Autoimmune Diseases Betsy Kirchner CNP The Cleveland Clinic Disclosures (financial) No relevant disclosures Learning Objectives Explain the pathophysiology of autoimmune disease Discuss safe administration
More informationAutoimmunity. Autoimmunity arises because of defects in central or peripheral tolerance of lymphocytes to selfantigens
Autoimmunity Autoimmunity arises because of defects in central or peripheral tolerance of lymphocytes to selfantigens Autoimmune disease can be caused to primary defects in B cells, T cells and possibly
More informationAlberta Health Public Health Notifiable Disease Management Guidelines December Subacute Sclerosing Panencephalitis (SSPE)
December 2015 Subacute Sclerosing Panencephalitis (SSPE) Revision Dates Case Definition Reporting Requirements Remainder of the Guideline (i.e., Etiology to References sections inclusive) Case Definition
More informationDetection of Epstein Barr virus infection subtype in patients with multiple sclerosis by indirect immunofluorescence assay
Original Article Detection of Epstein Barr virus infection subtype in patients with multiple sclerosis by indirect immunofluorescence assay Shan-Chao Zhang 1, Lei Liu 2, Rui-Jin Wang 1, Hou-Zhen Tuo 1,
More informationEPUB - EPSTEIN BARR AUTOIMMUNE DISEASE ARCHIVE
23 March, 2018 EPUB - EPSTEIN BARR AUTOIMMUNE DISEASE ARCHIVE Document Filetype: PDF 227.63 KB 0 EPUB - EPSTEIN BARR AUTOIMMUNE DISEASE ARCHIVE Epstein-Barr Virus can trigger seven autoimmune diseases
More informationViral pathophysiology of multiple sclerosis: A role for Epstein-Barr virus infection?
Pathophysiology 18 (2011) 13 20 Viral pathophysiology of multiple sclerosis: A role for Epstein-Barr virus infection? Amir-Hadi Maghzi a,b,c,, Monica Marta a, Isabel Bosca a,d, Masoud Etemadifar b,c, Ruth
More informationEpstein-Barr Virus in Cerebrospinal Fluid During Infectious Mononucleosis Encephalitis
THE YALE JOURNAL OF BIOLOGY AND MEDICINE 55 (1982), 59-63 Epstein-Barr Virus in Cerebrospinal Fluid During Infectious Mononucleosis Encephalitis JACK A. SCHIFF, M.D.,a JOHN A. SCHAEFER, M.B.B.S., F.R.A.C.P.,a
More informationSelf-tolerance. Lack of immune responsiveness to an individual s own tissue antigens. Central Tolerance. Peripheral tolerance
Autoimmunity Self-tolerance Lack of immune responsiveness to an individual s own tissue antigens Central Tolerance Peripheral tolerance Factors Regulating Immune Response Antigen availability Properties
More informationHerpes Simplex Virus Type 1 and Alzheimer s disease:
The Neurodegenerates Herpes Simplex Virus Type 1 and Alzheimer s disease: Increasing Evidence for a major role of the virus 1 Introduction and Agenda 2 Agenda What is the HSV1 and why is it linked to AD?
More informationPEDIATRIC MULTIPLE SCLEROSIS
PEDIATRIC MULTIPLE SCLEROSIS N E U R O G E N O M I C S L A B O R AT O R Y M U LT I P L E S C L E R O S I S C E N T E R S H E B A M E D I C A L C E N T E R Definitions Multiple sclerosis (MS), a chronic
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity
More informationReactivation of herpesvirus under fingolimod: A case of severe herpes simplex encephalitis
Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2015 Reactivation of herpesvirus under fingolimod: A case of severe herpes
More informationNEW CONCEPTS IN THE IMMUNOPATHOGENESIS OF MULTIPLE SCLEROSIS
NEW CONCEPTS IN THE IMMUNOPATHOGENESIS OF MULTIPLE SCLEROSIS Bernhard Hemmer*, Juan J. Archelos and Hans-Peter Hartung Multiple sclerosis (MS) is a commonly occurring inflammatory and demyelinating neurological
More informationCan HPV, cervical neoplasia or. HIV transmission?
Interactions between HPV and HIV: STIs and HIV shedding, regulation of HPV by HIV, and HPV VLP influence upon HIV Jennifer S. Smith Department of Epidemiology pd University of North Carolina Can HPV, cervical
More informationHow the Innate Immune System Profiles Pathogens
How the Innate Immune System Profiles Pathogens Receptors on macrophages, neutrophils, dendritic cells for bacteria and viruses Broad specificity - Two main groups of bacteria: gram positive, gram-negative
More informationBachelor of Chinese Medicine ( ) AUTOIMMUNE DISEASES
Bachelor of Chinese Medicine (2002 2003) BCM II Dr. EYT Chan February 6, 2003 9:30 am 1:00 pm Rm 134 UPB AUTOIMMUNE DISEASES 1. Introduction Diseases may be the consequence of an aberrant immune response,
More informationMedical Immunology Practice Questions-2016 Autoimmunity + Case Studies
Medical Immunology Practice Questions-2016 Autoimmunity + Case Studies Directions: Each of the numbered items or incomplete statements in this section is followed by answers or by completions of the statement.
More informationWhat can pediatric MS teach us about adult-onset MS?
What can pediatric MS teach us about adult-onset MS? Emmanuelle Waubant, MD, PhD University of California, San Francisco February 15, 2012 Multiple sclerosis in children Less frequent than in adults Childhood
More informationSurveillance for encephalitis in Bangladesh: preliminary results
Surveillance for encephalitis in Bangladesh: preliminary results In Asia, the epidemiology and aetiology of encephalitis remain largely unknown, particularly in Bangladesh. A prospective, hospital-based
More informationCase Report A case of EBV positive diffuse large B-cell lymphoma of the adolescent
Int J Clin Exp Med 2014;7(1):307-311 www.ijcem.com /ISSN:1940-5901/IJCEM1311029 Case Report A case of EBV positive diffuse large B-cell lymphoma of the adolescent Qilin Ao 2, Ying Wang 1, Sanpeng Xu 2,
More informationInnovation in Diagnostics. ToRCH. A complete line of kits for an accurate diagnosis INFECTIOUS ID DISEASES
Innovation in Diagnostics ToRCH A complete line of kits for an accurate diagnosis INFECTIOUS ID DISEASES EN TOXOPLASMOSIS Toxoplasmosis is a parasitic disease caused by with the obligate intracellular
More informationLarge DNA viruses: Herpesviruses, Poxviruses, Baculoviruses and Giant viruses
Large DNA viruses: Herpesviruses, Poxviruses, Baculoviruses and Giant viruses Viruses are the only obstacles to the domination of the Earth by mankind. -Joshua Lederberg Recommended reading: Field s Virology
More information1. Overview of Adaptive Immunity
Chapter 17A: Adaptive Immunity Part I 1. Overview of Adaptive Immunity 2. T and B Cell Production 3. Antigens & Antigen Presentation 4. Helper T cells 1. Overview of Adaptive Immunity The Nature of Adaptive
More informationEBV and Infectious Mononucleosis. Infectious Disease Definitions. Infectious Diseases
Infectious Disease Definitions Infection when a microorganism invades a host and multiplies enough to disrupt normal function by causing signs and symptoms Pathogencity ability of an organism to cause
More informationGastric Carcinoma with Lymphoid Stroma: Association with Epstein Virus Genome demonstrated by PCR
Gastric Carcinoma with Lymphoid Stroma: Association with Epstein Virus Genome demonstrated by PCR Pages with reference to book, From 305 To 307 Irshad N. Soomro,Samina Noorali,Syed Abdul Aziz,Suhail Muzaffar,Shahid
More informationDiseases of Immunity 2017 CL Davis General Pathology. Paul W. Snyder, DVM, PhD Experimental Pathology Laboratories, Inc.
Diseases of Immunity 2017 CL Davis General Pathology Paul W. Snyder, DVM, PhD Experimental Pathology Laboratories, Inc. Autoimmunity Reflects a loss of immunologic tolerance Mechanisms Auto-antibodies
More informationRestricted VZV transcription in human trigeminal ganglia
JVI Accepts, published online ahead of print on 27 June 2012 J. Virol. doi:10.1128/jvi.01331-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Restricted VZV transcription
More informationCentral tolerance. Mechanisms of Immune Tolerance. Regulation of the T cell response
Immunoregulation: A balance between activation and suppression that achieves an efficient immune response without damaging the host. Mechanisms of Immune Tolerance ACTIVATION (immunity) SUPPRESSION (tolerance)
More informationMechanisms of Immune Tolerance
Immunoregulation: A balance between activation and suppression that achieves an efficient immune response without damaging the host. ACTIVATION (immunity) SUPPRESSION (tolerance) Autoimmunity Immunodeficiency
More informationMAF Shalaby Prof. Rheumatology Al Azhar University, Cairo, Egypt.
MAF Shalaby Prof. Rheumatology Al Azhar University, Cairo, Egypt. AUTOIMMUNE DISEASE RA SLE VASCULITIS RELAPSING POLYCHONDRITIS SS DM/PM SJOGREN S SYNDROME RHEUMATOID ARTHRITIS Classically immune mediated
More informationNew Insights on Mechanisms of Foamy Macrophage (FM) Induction and Persistence
New Insights on Mechanisms of Foamy Macrophage (FM) Induction and Persistence Marian Laderoute, Ph.D. Medical Sciences -Immunology Lab Director Immune System Management Clinic & Lab 80 Aberdeen Street,
More informationMULTIPLE SCLEROSIS PROFILE
MULTIPLE SCLEROSIS PROFILE What is Multiple Sclerosis? Multiple sclerosis (MS) is a chronic, inflammatory disease of unknown etiology that involves an immune-mediated attack on the central nervous system
More informationTopic (Final-03): Immunologic Tolerance and Autoimmunity-Part II
Topic (Final-03): Immunologic Tolerance and Autoimmunity-Part II MECHANISMS OF AUTOIMMUNITY The possibility that an individual s immune system may react against autologous antigens and cause tissue injury
More informationAppendix B: Provincial Case Definitions for Reportable Diseases
Infectious Diseases Protocol Appendix B: Provincial Case Definitions for Reportable Diseases Disease: Measles Revised August 2014 Measles 1.0 Provincial Reporting Confirmed and probable cases of disease
More informationPersistent Infections
Persistent Infections Lecture 16 Virology W3310/4310 Spring 2013 1 Breaking Up Is Hard To Do Neil Sedaka 1962 2 Acute vs. Persistent Infections Acute - a natural infection that usually is rapid and self
More informationKappa/lambda Ratios of IgG, IgA and IgM in the Cerebrospinal Fluid of Patients
Original Article Kappa/lambda Ratios of IgG, IgA and IgM in the Cerebrospinal Fluid of Patients with Syndrome Shigeru ARAGA, Hiroshi KAGIMOTO, Akiko ADACHI, Koji FUNAMOTO,Kazuhiko INOUE and Kazuro TAKAHASHI
More informationSection Lectures: Immunology/Virology Time: 9:00 am 10:00 am LRC 105 A & B
Section Director: Cliff Bellone, Ph.D. Office: Doisy Hall - R 405 Phone: 577-8449 E-Mail: bellonec@slu.edu Lecturers: James Swierkosz, Ph.D. Office: Medical School Rm. 412 Phone: 577-8430 E-Mail: swierkoszje@slu.edu
More informationBBS2711 Virology. Central Nervous System (CNS) Viruses. Dr Paul Young, Department of Microbiology & Parasitology.
BBS2711 Virology Central Nervous System (CNS) Viruses Dr Paul Young, Department of Microbiology & Parasitology. p.young@mailbox.uq.edu.au Viruses of the CNS Many human pathogenic viruses are capable of
More informationMulti-Virus-Specific T cell Therapy for Patients after HSC and CB Transplant
Multi-Virus-Specific T cell Therapy for Patients after HSC and CB Transplant Hanley PJ, Krance BR, Brenner MK, Leen AM, Rooney CM, Heslop HE, Shpall EJ, Bollard CM Hematopoietic Stem Cell Transplantation
More informationHealing After Plague: Lessons Applied. Emerging Concepts
Healing After Plague: Lessons Applied Emerging Concepts Recombination events in animal and human cells can generate families of infectious related gamma retroviruses Greatest concern is that they have
More informationThe Neurology of HIV Infection. Carolyn Barley Britton, MD, MS Associate Professor of Clinical Neurology Columbia University
The Neurology of HIV Infection Carolyn Barley Britton, MD, MS Associate Professor of Clinical Neurology Columbia University HIV/AIDS Epidemiology World-wide pandemic, 40 million affected U.S.- Disproportionate
More informationAcute neurological syndromes
Acute neurological syndromes Assoc.Prof. Murat Sayan Kocaeli Üniversitesi, Rutin PCR Lab. Sorumlu Öğt.Üyesi Yakın Doğu Üniversitesi, DESAM Kurucu Öğrt. Üyesi sayanmurat@hotmail.com 0533 6479020 Medical
More informationSEVENTH EDITION CHAPTER
Judy Owen Jenni Punt Sharon Stranford Kuby Immunology SEVENTH EDITION CHAPTER 16 Tolerance, Autoimmunity, and Transplantation Copyright 2013 by W. H. Freeman and Company Immune tolerance: history * Some
More informationWhat will we discuss today?
Autoimmune diseases What will we discuss today? Introduction to autoimmune diseases Some examples Introduction to autoimmune diseases Chronic Sometimes relapsing Progressive damage Epitope spreading more
More informationChronic Infectious Mononucleosis/EBV Management
Chronic Infectious Mononucleosis/EBV Management Hypothesis Continuous or intermittent Epstein-Barr virus (EBV) replication after primary EBV infection causes tissue damage resulting in a myriad of symptoms.
More informationEpstein-Barr virus and immunity
Epstein-Barr virus and immunity Elena Kashuba, PhD Associate Professor Department of Microbiology, Tumor and Cell Biology (MTC) Karolinska Institutet 1 Epstein-Barr virus EBV Everybody s virus 200 nm Enveloped
More informationViruses. Poxviridae. DNA viruses: 6 families. Herpesviridae Adenoviridae. Hepadnaviridae Papovaviridae Parvoviridae
Viruses DNA viruses: 6 families Poxviridae Herpesviridae Adenoviridae Hepadnaviridae Papovaviridae Parvoviridae Human herpesviruses Three subfamilies (genome structure, tissue tropism, cytopathologic effect,
More informationKey issues in varicella-zoster virus latency
Journal of NeuroVirology, 8(suppl. 2): 80 84, 2002 c 2002 Taylor & Francis ISSN 1355 0284/02 $12.00+.00 DOI: 10.1080/13550280290101058 Key issues in varicella-zoster virus latency Peter GE Kennedy Department
More informationImmunological Tolerance
Immunological Tolerance Introduction Definition: Unresponsiveness to an antigen that is induced by exposure to that antigen Tolerogen = tolerogenic antigen = antigen that induces tolerance Important for
More informationParallel session IVB. Chair: Hans Wildiers
Parallel session IVB Biology of ageing and cancer Chair: Hans Wildiers IMMUNOSENESCENCE AND AGEING Tamas Fulop M.D., PhD Research Center on Aging, Division of Geriatrics, University of Sherbrooke, Sherbrooke,
More informationReview Article CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis
Autoimmune Diseases Volume 2012, Article ID 189096, 16 pages doi:10.1155/2012/189096 Review Article CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity:
More informationViral Hepatitis Diagnosis and Management
Viral Hepatitis Diagnosis and Management CLINICAL BACKGROUND Viral hepatitis is a relatively common disease (25 per 100,000 individuals in the United States) caused by a diverse group of hepatotropic agents
More informationMOLECULAR IMMUNOLOGY Manipulation of immune response Autoimmune diseases & the pathogenic mechanism
MOLECULAR IMMUNOLOGY Manipulation of immune response Autoimmune diseases & the pathogenic mechanism SCHMAIEL SHIRDEL CONTENT 2 Introduction Autoimmune diseases Classification Involved components Autoimmune
More informationMultiple Choice Questions - Paper 1
Multiple Choice Questions - Paper 1 Instructions for candidates The examination consists of 30 multiple choice questions, each divided into 5 different parts. Each part contains a statement which could
More informationAlessandra Franco, M.D., Ph.D. UCSD School of Medicine Department of Pediatrics Division of Allergy, Immunology and Rheumatology
Natural regulatory T cells recognize the heavy constant region (Fc) of immunoglobulins: a novel mechanism for IVIG immunotherapy in Pediatric Immune-mediated diseases Alessandra Franco, M.D., Ph.D. UCSD
More informationWhat is a cause? Dr Brendan Clarke. UCL Department of Science and Technology Studies
What is a cause? Dr Brendan Clarke UCL Department of Science and Technology Studies Causation is important to medicine Causation is important to medicine Causal relations imply something beyond mere association
More informationImmune system. Aims. Immune system. Lymphatic organs. Inflammation. Natural immune system. Adaptive immune system
Aims Immune system Lymphatic organs Inflammation Natural immune system Adaptive immune system Major histocompatibility complex (MHC) Disorders of the immune system 1 2 Immune system Lymphoid organs Immune
More information